Vericel Denmark ApS: Financial statements 2015
CVR: 19740986
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
Vericel Denmark ApS (CVR 19740986) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -236,339 and a net result of DKK 791,964 compared with DKK -13,614,809 the year before. Equity in the 2015 report amounted to DKK 8,368,159. The solvency ratio was 85.8%.
- Gross Profit
- DKK -236,339
- Profit/Loss
- DKK 791,964
- Equity
- DKK 8,368,159
- Total Assets
- DKK 9,754,017
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -236 t. | 792 t. | 8.4 mio. | - |
| 2014 | - | 3.3 mio. | -13.6 mio. | 7.6 mio. | - |
| 2013 | - | 55.1 mio. | -4.2 mio. | 33 mio. | - |
| 2012 | - | 23.5 mio. | 3.7 mio. | 37.2 mio. | - |
Official annual report
How creditworthy is Vericel Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
Vericel Denmark ApS has published its annual report for 2014. Gross profit came to DKK 3,321,009, and the net result was DKK -13,614,809.
On March 25, 2015, the company changed its name from AASTROM BIOSCIENCES DK ApS to Vericel Denmark ApS.
About Vericel Denmark ApS
Vericel Denmark ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AASTROM BIOSCIENCES DK ApS and GENZYME BIOSURGERY ApS. The management consists of Joseph Anthony Mara Jr. The company is owned by Vericel Corporation. The company has 0 employees (2015). In 2025, the company reported a gross profit of DKK -128,481 and a net result of DKK -128,481 compared with DKK -109,464 the year before. Equity in the 2025 report amounted to DKK 6,241,335.